510(k) Report

PMA · Approved

Approved

Liverty™ TIPS Stent Graft

P250050PMAApproved Sep 25, 2026303-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bard Peripheral Vascular, Inc. · MIR Shunt, Portosystemic, Endoprosthesis

Approved on Sep 25, 2026 through premarket approval, which rests on the device’s own clinical evidence after a 303-day review.

Decided
Sep 25, 2026
Review
303 days
Class
Class III
Product code
MIR
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P250050 has 1 supplement since 2026: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2026: 1
2026high 1 (2026) · low 0 (2027)2027
View FIG. 1 as a table
YearSupplements approved
20261
FIG. 1 — Supplements to P250050, 2026–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MIR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All MIR devices

MIR Shunt, Portosystemic, Endoprosthesis: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · MIR

2in 2025

2007: 42008: 62009: 62010: 52011: 62012: 102013: 162014: 72015: 92016: 92017: 82018: 102019: 112020: 82021: 72022: 62023: 42024: 62025: 22026 (partial year): 2
2007high 16 (2013) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MIR

Too few MIR 510(k)s in any year since 2007 to give a median.

Recalls per year · MIR

No recall names MIR since 2007.

Adverse event reports per year · MIR

16in 2025

2007: 12008: 42009: 62010: 82011: 72012: 92013: 112014: 82015: 62016: 82017: 132018: 202019: 292020: 142021: 132022: 232023: 222024: 402025: 16
2007high 40 (2024) · low 1 (2007)2025

MAUDE reports naming product code MIR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074—01
20086—04
20096—06
20105—08
20116—07
201210—09
201316—011
20147—08
20159—06
20169—08
20178—013
201810—020
201911—029
20208—014
20217—013
20226—023
20234—022
20246—040
20252—016
20262—0—
Cite this page

510(k) Report. “P250050: Liverty™ TIPS Stent Graft.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P250050

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Page last updated Nov 3, 2026